Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects

@inproceedings{Omoto2015ClinicalSO,
  title={Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects},
  author={Yoko Omoto and Hirotaka Iwase},
  booktitle={Cancer science},
  year={2015}
}
Breast and prostate cancers are among the most common of all cancers. They are referred to as hormone-dependent cancers, because estrogen and androgen are involved in their development and growth. The effects of these hormones are mediated by their respective receptors, estrogen receptor (ER) α and androgen receptor. Around 18 years ago, a second ER, ERβ, which has a very similar structure to ERα, was discovered. Its function has been investigated using a variety of methods and biological… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Hormonwirkungen chinesischer Arzneidrogen

Chinesische Medizin / Chinese Medicine • 2018
View 3 Excerpts
Highly Influenced

Potent aromatase inhibitors and molecular mechanism of inhibitory action.

European journal of medicinal chemistry • 2018
View 1 Excerpt

Oestrogen receptor expression in melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 76 references

Differential expression of estrogen receptor alpha , beta 1 , and beta 2 in lobular and ductal breast cancer

Y Omoto
Proc Natl Acad Sci U S A • 2014

and causes induction of apoptosis through PUMA in prostate cancer

P Toren, A. Zoubeidi
Oncogene • 2014

tamoxifen-resistant breast cancer cells via stimulation by the ERK1 ⁄ 2 and AKT signaling pathways

EM CiruelosGil
Oncol Rep • 2013

Estro - gen receptors beta 1 and beta 2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC 3

P Jonsson, J Hartman, JA Gustafsson
2012

cancer: an evaluation of factors that influence patient outcomes

J Baselga, M Campone, M Piccart
Breast Cancer 2014; • 2012

Development of subtypeselective oestrogen receptorbased therapeutics

KF Koehler, JA Gustafsson
Nat Rev Drug Discovery • 2011

oestrogen receptor-based therapeutics

A Pravettoni, O Mornati, PG Martini
Nat Rev Drug Discovery • 2011

Similar Papers

Loading similar papers…